Talphera, Inc. (TLPH)
0.8156
-0.03
(-3.68%)
USD |
NASDAQ |
Jun 09, 16:00
0.8319
+0.02
(+2.00%)
After-Hours: 20:00
Talphera SG&A Expense (Quarterly) : 2.298M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Aytu Biopharma, Inc. | 10.90M |
| Aquestive Therapeutics, Inc. | 10.98M |
| ANI Pharmaceuticals, Inc. | 73.66M |
| Corcept Therapeutics, Inc. | 145.36M |
| Assertio Holdings, Inc. | 11.14M |